These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1377080)
1. Effects of intravenous infusion of substance P on arginine vasopressin and oxytocin secretion in normal men. Chiodera P; Coiro V Brain Res; 1992 Jan; 569(1):173-6. PubMed ID: 1377080 [TBL] [Abstract][Full Text] [Related]
2. Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on arginine vasopressin and oxytocin secretion in man. Chiodera P; Volpi R; Capretti L; Coiro V Neuroreport; 1995 Jul; 6(11):1490-2. PubMed ID: 7579131 [TBL] [Abstract][Full Text] [Related]
3. Arginine vasopressin and oxytocin responses to angiotensin II are mediated by AT1 receptor subtype in normal men. Chiodera P; Volpi R; Caiazza A; Giuliani N; Magotti MG; Coiro V Metabolism; 1998 Aug; 47(8):893-6. PubMed ID: 9711980 [TBL] [Abstract][Full Text] [Related]
4. Effect of chronic hyponatremia on central and peripheral oxytocin and vasopressin secretion in rats. Iványi T; Dohanics J; Verbalis JG Neuroendocrinology; 1995 Apr; 61(4):412-20. PubMed ID: 7783854 [TBL] [Abstract][Full Text] [Related]
5. Naloxone increases the angiotensin II stimulated rise of arginine vasopressin and oxytocin secretion in man. Coiro V; Chiodera P Neuroendocrinology; 1991 Mar; 53(3):209-13. PubMed ID: 2041583 [TBL] [Abstract][Full Text] [Related]
6. Luteinizing hormone response to an intravenous infusion of substance P in normal men. Coiro V; Volpi R; Capretti L; Caiazza A; Marcato A; Bocchi R; Colla R; Rossi G; Chiodera P Metabolism; 1992 Jul; 41(7):689-91. PubMed ID: 1377769 [TBL] [Abstract][Full Text] [Related]
7. Preferential release of oxytocin in response to vasoactive intestinal polypeptide in rats. Bardrum B; Ottesen B; Fuchs AR Life Sci; 1987 Jan; 40(2):169-73. PubMed ID: 3796218 [TBL] [Abstract][Full Text] [Related]
8. Opioid-mediated inhibition of oxytocin during insulin-induced hypoglycemic stimulation of vasopressin in man. Seckl JR; Haddock JA; Dunne MJ; Lightman SL Acta Endocrinol (Copenh); 1988 May; 118(1):77-81. PubMed ID: 2838996 [TBL] [Abstract][Full Text] [Related]
9. Vasopressin and oxytocin responses to acute and chronic osmotic stimuli in man. Williams TD; Abel DC; King CM; Jelley RY; Lightman SL J Endocrinol; 1986 Jan; 108(1):163-8. PubMed ID: 3944536 [TBL] [Abstract][Full Text] [Related]
10. Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal polypeptide. Bardrum B; Ottesen B; Fahrenkrug J; Fuchs AR Endocrinology; 1988 Nov; 123(5):2249-54. PubMed ID: 3168920 [TBL] [Abstract][Full Text] [Related]
11. Histaminergic and catecholaminergic interactions in the central regulation of vasopressin and oxytocin secretion. Knigge U; Willems E; Kjaer A; Jørgensen H; Warberg J Endocrinology; 1999 Aug; 140(8):3713-9. PubMed ID: 10433231 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory control of nitric oxide on the arginine-vasopressin and oxytocin response to hypoglycaemia in normal men. Chiodera P; Volpi R; Coiro V Neuroreport; 1994 Sep; 5(14):1822-4. PubMed ID: 7530064 [TBL] [Abstract][Full Text] [Related]
13. Gamma-aminobutyric acid mediation of the inhibitory effect of nitric oxide on the arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia. Chiodera P; Volpi R; Capretti L; Coiro V Regul Pept; 1996 Nov; 67(1):21-5. PubMed ID: 8952001 [TBL] [Abstract][Full Text] [Related]
14. Endogenous opioids inhibit oxytocin release during nicotine-stimulated secretion of vasopressin in man. Seckl JR; Johnson M; Shakespear C; Lightman SL Clin Endocrinol (Oxf); 1988 May; 28(5):509-14. PubMed ID: 3214943 [TBL] [Abstract][Full Text] [Related]
15. Vasopressin and oxytocin release as influenced by thyrotropin-releasing hormone in euhydrated and dehydrated rats. Ciosek J J Physiol Pharmacol; 2002 Sep; 53(3):423-37. PubMed ID: 12369739 [TBL] [Abstract][Full Text] [Related]
16. Vasopressin and oxytocin levels during normal pregnancy: effects of chronic dietary sodium restriction. van der Post JA; van Buul BJ; Hart AA; van Heerikhuize JJ; Pesman G; Legros JJ; Steegers EA; Swaab DF; Boer K J Endocrinol; 1997 Mar; 152(3):345-54. PubMed ID: 9071954 [TBL] [Abstract][Full Text] [Related]
17. Clonidine decreases plasma and cerebrospinal fluid arginine vasopressin but not oxytocin in humans. Peskind ER; Raskind MA; Leake RD; Ervin MG; Ross MG; Dorsa DM Neuroendocrinology; 1987 Nov; 46(5):395-400. PubMed ID: 3431654 [TBL] [Abstract][Full Text] [Related]
18. Vasopressin and oxytocin responses to hypertonic saline infusion: effect of the opioid antagonist naloxone. Seckl JR; Johnson MR; Lightman SL Clin Endocrinol (Oxf); 1989 May; 30(5):513-8. PubMed ID: 2605788 [TBL] [Abstract][Full Text] [Related]
19. The effect of hemorrhage and hypertonic saline upon plasma oxytocin and arginine vasopressin in conscious dogs. Weitzman RE; Glatz TH; Fisher DA Endocrinology; 1978 Dec; 103(6):2154-60. PubMed ID: 748039 [TBL] [Abstract][Full Text] [Related]
20. Naloxone affects the release of cortisol, but not of vasopressin or oxytocin, in dehydrated sheep. Thornton SN; Parrott RF Acta Endocrinol (Copenh); 1989 Jan; 120(1):50-4. PubMed ID: 2911940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]